The E3 ligase TRIM21 promotes progression of pancreatic ductal adenocarcinoma by down-regulating TAp63α and derepressing IL20RB
Science Signaling · 2025
DOI: 10.1126/scisignal.adv4579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Zejiao Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center of Growth, Metabolism, and Aging, Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichu…. Hauptthemen laut MEDLINE: Ribonucleoproteins, Ubiquitin-Protein Ligases, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumor and frequently has mutations in the transcription factor p53. TAp63α is a member of the p53 protein family that is generally tumor suppressive in various other p53-mutant or p53-deficient cancers. Here, we found that TAp63α inhibited cell proliferation, epithelial-mesenchymal transition (EMT), and migration in several p53-mutant PDAC cell lines. TAp63α transcriptionally repressed IL20RB (which encodes a subunit of the interleukin-20 receptor), potentially by inducing the methylation of its promoter. However, mutations in p53 or KRAS that are common in PDAC increased the abundance of the E3 ligase TRIM21, which promoted the ubiquitin-dependent degradation of TAp63α. Thus, the degradation of TAp63α enabled increases in IL20RB expression and formation of IL-20 receptors, resulting in the activation of downstream JAK1-STAT3 signaling that stimulated the proliferation, EMT, migration, and in vivo metastatic seeding of PDAC cells. Our findings identify a signaling axis involving TRIM21, TAp63α, and IL-20RB in PDAC progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Growth, Metabolism, and Aging, Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610064, Sichuan, China.
- Liver Transplantation Center, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu 610041, Sichuan, China.
- College of Life Sciences, China West Normal University, Nanchong 637009, Sichuan, China.
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610064, Sichuan, China.
ORCID-Profile: Zejiao Li, Fengwei Gao, Xuesha Liu, Shijie Fan, Yucheng Qi, Xiaoyun Nie, Zhi-Xiong Jim Xiao, Chenghua Li
Zitieren
APA
Li, Z., Gao, F., Liu, X., Fan, S., Qi, Y., He, M., Luo, X., Nie, X., Wang, J., Wang, Y., Xiao, Z. J., & Li, C. (2025). The E3 ligase TRIM21 promotes progression of pancreatic ductal adenocarcinoma by down-regulating TAp63α and derepressing IL20RB. Science Signaling. https://doi.org/10.1126/scisignal.adv4579
Vancouver
Li Z, Gao F, Liu X, Fan S, Qi Y, He M, et al. The E3 ligase TRIM21 promotes progression of pancreatic ductal adenocarcinoma by down-regulating TAp63α and derepressing IL20RB. Science Signaling. 2025. doi:10.1126/scisignal.adv4579
BibTeX
@article{Li2025,
author = {Li, Zejiao and Gao, Fengwei and Liu, Xuesha and Fan, Shijie and Qi, Yucheng and He, Mingzhu and Luo, Xiushuang and Nie, Xiaoyun and Wang, Jia and Wang, Yajun and Xiao, Zhi-Xiong Jim and Li, Chenghua},
title = {The E3 ligase TRIM21 promotes progression of pancreatic ductal adenocarcinoma by down-regulating TAp63α and derepressing IL20RB},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adv4579}
}
EUVIMED